FREETHINK TECHNOLOGIES - Key Persons
Job Titles:
- Business Development Manager
Dave received his B.S. from Springfield College and has >20 years of pharmaceutical industry experience, including pharmaceutical sciences supply chain management and clinical development operations. While at Pfizer, Dave was a senior leader on the industry's first full-scale flexible resource model for global clinical trial management, and in 2013 he founded the consulting firm Verdure Bay to offer flexible expertise in product development. Dave joined FreeThink in 2018 to help lead global business development strategy and execution.
Job Titles:
- Member of the Chief Science Officer and Member of Board
- Member of the Leadership Team
- Chief Science Officer and Member of Board
Alisa Waterman received her B.A. (Wesleyan University) and Ph.D. (Albert Einstein College of Medicine), and completed post-doctoral studies (Yale University) before spending 24 years at Boehringer Ingelheim (as a Senior Research Fellow) championing discovery and development of biological and small molecule drug candidates. In 2015 she joined FreeThink Technologies where she currently manages the customer portfolio of projects.
Job Titles:
- Member of the Leadership Team
- Technology Development Lead
Jennifer Chu received her B.S.E. (Princeton University) and Ph.D. (University of Texas, Austin) before spending 7 years at Pfizer (as a Senior Principal Scientist) followed by work at a series of small biotech companies (Neurogen, Ikaria, Achillion as an Executive Director of Pharmaceutical Sciences). She joined FreeThink in 2018 where she leads formulation development and manages FreeThink's new technology development.
Job Titles:
- Chairman of the Board
- Member of the Leadership Team
- President
After receiving his B.S. (UCLA) and Ph.D. (UC Berkeley) in physical-organic chemistry, Kenneth Waterman completed post-doctoral studies (Columbia University) before spending 12 years at Polaroid (as a distinguished scientist), then 13 years at Pfizer (as a Research Fellow). He has successfully invented and commercialized a number of products and is the author of over 75 publications. He was made an AAPS Fellow in 2011 the same year he started FreeThink Technologies.
Job Titles:
- Associate Director, Physical Sciences
Patrick Kelleher received his B.S. (Stonehill College) and Ph.D. (Yale University) in physical chemistry before completing post-doctoral studies at the University of Virginia. His graduate and post-doctoral work focused on the development of spectroscopic and mass-spectrometric techniques for structural elucidation of small molecules. Patrick joined FreeThink in 2020 where he currently leads the physical sciences department.
Job Titles:
- Associate Research Fellow at Pfizer in Sandwich, UK.
He has a B.Sc. in Chemistry and a D.Phil in the application of magnetic resonance spectroscopy (ESR and NMR) to determine the mechanisms and kinetics of organic oxidation reactions. He has over 25 years of experience in analytical chemistry in the pharmaceutical industry, working in areas ranging from inhalation to dissolution, and has authored numerous regulatory submissions. In recent years, Garry focuses on pharmaceutical stability and has helped to develop, refine, and apply accelerated studies for the prediction of long-term stability performance. Garry has authored numerous scientific papers and recently co-authored a book on "Accelerated Predictive Stability." Garry's role at Pfizer also includes troubleshooting pharmaceutical product problems, understanding causes of poor stability, and improving product design.
Job Titles:
- Member of the Leadership Team
- Member of the Vice President and Secretary of Board
- Vice President and Secretary of Board
Mark Kastan received his B.A. (Washington University) and MBA (University of Rochester). He worked on Wall Street for 17 years (Credit Suisse First Boston, Merrill Lynch) as an equity analyst. He helped found FreeThink Technologies in 2011 and currently heads the software division and manages company finances.
Dr. Hemingway graduated from the University of Hull in 2012 with a Ph.D. in Chemistry under the supervision of Steve Archibald, developing tumor-targeted therapeutics. The multidisciplinary project allowed her to develop skills in organic, analytical, coordination chemistry, and cell culture. After two and a half years working as a research scientist for a chemical manufacturer, Rachel joined Lhasa Limited. She has been part of the science team at Lhasa for over 8 years, working almost exclusively on the software program Zeneth. As a principal scientist, Rachel leads a team of scientists who develop the Zeneth knowledge base while influencing the software's strategy and direction. Her interests lie in developing software tools to address knowledge gaps and support decision-making in the degradation community. She has co-authored five journal articles (one in preparation) and four book chapters.
Job Titles:
- Member of the Member of Board
- Owner of the Accounting Firm Waterman
Richard Waterman is owner of the accounting firm Waterman and Associates. He received his B.S.E. (UCLA) and MBA in accounting (San Jose State). He is a member of the Campbell, California city council. He advises FreeThink on financial matters.
Job Titles:
- President of Baertschi Consulting
A firm specializing in solutions to the most difficult stability, impurity, analytical, solid-state, and formulation issues. Retiring from Lilly in 2015, he brings 30 years of experience in the pharmaceutical industry to his consulting firm, with a demonstrated track record of innovation and problem-solving. He obtained his Ph.D. in Organic Chemistry in 1989 from Vanderbilt University, joining Lilly that same year.
Dr. Baertschi has organized/chaired numerous scientific conferences / symposia on stress testing, stability, photostability, and impurities, and has published extensively in these areas, including two editions of a book on pharmaceutical stress testing / drug degradation. Dr. Baertschi is a member of the American Chemical Society, the American Association of Pharmaceutical Scientists (AAPS), is a Fellow of the AAPS (since 2007).